Tweet
Ever go out drinking all night and come home tired with a belly full of beer? Everything is excellent and you are more than prepared to sleep like a baby. You throw your clothes all over the room and then dive into bed. Another Saturday night success!
All of a sudden you start having these weird dreams. You’re driving in a car and need to pull over to the side of the road to go siss. Or, you’re at a football game and you get up to go to the men’s room and you can’t find it. Or you’re back in high school, and you ask the teacher for a hall pass, and he doesn’t give it to you. Finally, you wake up with the revelation that you have to go siss like a Russian race horse. So you go to your bathroom, open up your fire hose, take care of bitness and go try to go back to sleep. The only problem is that now your head is throbbing like 10 pounds of poop in a 3 pound bag.
Or how about this scenario? You schedule a morning meeting at 10 am. This way you get to sleep an extra hour. But at 6 am, you get that urge to go siss. You get up and take care of bitness, but now you can’t go back to sleep.
Or how about this story? Titan Omega went up on the roof to siss. He gets too close to the edge and takes the fast elevator down.
Or how about this story? A Yale graduate and a Wharton MBA wakes up in the middle of the night, sleepwalks to his refrigerator and waters his lettuce.
All of these stories are true and truth IS stranger than fiction.
Wouldn’t it be great if there were some ancient Chinese herb you could take to make you suppress the urge to go siss when you don’t really have to? Now you don’t have to dream.
Today I bought AOB, American Oriental Bioengineering, at 12.25. I will sell it in 4 - 6 weeks 14.15. Here’s why I like AOB:
AOB’s stock is up 184% in the last 12 months, yet it’s still very cheap. Even though its present P/E is 33, it’s accelerating growth and earnings puts its forward P/E ratio at only 22. Look at this chart…it’s ramping up:
American Oriental Bioengineering, Inc. engages in the development and production of plant-based pharmaceutical (PBP) products and plant-based nutraceutical (PBN) products in China. Its PBP products include cease enuresis soft gel, which is used to alleviate bed-wetting and urination disorder; double ginseng yishen grain that is used for neurosis, vegetative nerve functional disturbance, and hypo-immunity; root of red-rooted salvia tablet that improves blood circulation and blood flow to the coronary artery to relieve pain, and is used for coronary ischemia and angina pectoris caused by coronary heart disease; and urinstopper patch, which is used to avoid frequent urination, urinal incontinence, and bed wetting.
Their two big products are SoyPeptide Beverage. The product contains Soybean Peptide which is extracted from the Soy Protein Isolate through enzyme reaction, is composed of 3 to 6 amino acid with molecular weight less than 1,000d. Peptide is absorbed and digested by our body more directly than amino acid, is low in sensitivity and zero in cholesterol that is good to health. It also consists of complete plant protein, rich in 9 kinds of essential amino acids that make rapid recovery of energy, as well as accelerating the power of brain. Further, it is also good for energy metabolism. This product is added with soybean peptide and condensed ribes nigrum, which is rich in vitamins and minerals, is very good to our health.
The other one is Cease-enuresis soft gel
Chinese spelling：Yiniaoting Jiaonang
Ingredients】Hulled seed cream of shinyleaf yellowhorn.
Character】 This products are in brown granules, slightly sweet and acerbity in flavor
Pharmacological action】 This product can reduce micturition times of water loading in mice; increase sphincter vesicae discharge frequency of a rat, enlarging scope,as well as prolong discharge period, as a result shrink sphincter vesicae. The in vitro studies indicated this product also can resist the shrinkage of white rat's bladder smooth muscle caused by acetylcholine, as well as reduce its tension. What? No more shrinkage? Now I can go in the pool?
We all agree that medicine is getting expensive. People, wisely, will turn to non-prescription herbal products if they work. How do you know if they work? Word of mouth is the tried and true way. This stuff actually seems to be working. How do I know this? Do people buy Ipods? People are buying AOB’s products. It seems to work, and people like telling their friends about it, especially if it works.
AOB has, in the last ten years, grown from a start-up in 1994 with about $100,000 of revenue to become a leading manufacturer of plant-based pharmaceutical products and plant-based nutraceutical products for the rapidly growing Chinese market. They operate in a large and growing market. The total pharmaceutical and nutraceutical market in China was approximately $62 billion in 2004. Demographic trends in this market are favorable, as the Chinese population continues to grow and age and economic expansion in China creates wealth, which serves to increase the number of citizens who can afford healthcare. With the total market for pharmaceutical products in China, herbal and plant-based pharmaceutical remedies and products have an extensive history. Many Chinese consumers and doctors rely upon the use of plant-based products for treatment of a variety of different ailments, consistent with the Eastern philosophy of health and wellness. AOB's standing could open the way to a raft of new biotech developed foods in China, particularly as the country races to meet rising demand for processed foods in an effort to feed its still burgeoning population – currently said to stand at 1.3 billion people. The supply of soy products has proved particularly problematic in recent years, leading the country to become a net importer of soybeans.
The company's research team reports that the growth of liver cancer cells inside mice was ‘successfully suppressed' by soybean protein peptides without side effects. Their findings could lead to future market opportunities for the ingredient. Soy is the most widely used botanical by pre- and post-menopausal women but its use by men is also growing as research continues to show the benefits on heart health. In the US, soy sales have grown from $940 million in 1990 to a projected $4 billion this year.
AOB currently has more than 100 products in their portfolio, all plant-based in formulation divided into two key categories: plant-based pharmaceuticals and plant-based nutraceuticals. PBP is the larger of the Company’s two divisions as a percentage of revenue. PBP products in China require approval from the state FDA and are administered both through over-the-counter locations and through prescriptions at hospitals and clinics. The two largest products in the PBP category are Shuanghuanglian Powder Injection and Cease Enuresis Soft Gel. SLPI, our largest contributing product, as a percent of total revenue is one of the only two PBP herbal injections approved by the China state FDA for treating anti-viral indications. Cease Enuresis Soft Gel is approved by the China state FDA as a prescription remedy for chronic bedwetting and nighttime urination. Bedwetting is a serious problem affecting millions of children and adults. Leveraging on our Cease-Enuresis Soft Gel and the newly established research center, we believe the Company can capture a substantial market share of serving patients suffering from enuresis or chronic bedwetting syndrome
PBN is the smaller of the Company’s two divisions. PBN products are not licensed by the China state FDA, but they generally require local government approval and are typically sold over the counter at the retail outlets. AOBO’s PBN division products soybean peptide products in powder and liquid forms. Soybean peptide is a cholesterol-free energy-boosting protein source that enhances the immune system and has anti-fatigue benefits. AOBO also produces a line of nutritional products through the PBN division, including the Three-Happiness nutritional drink, which are rich in vitamins and amino acids to enhance well-being and to provide energy The Three-Happiness product line is a recognized retail brand name in China.
AOB owns a very recognizable brand in China with their Three-Happiness nutritional beverages and the soy protein peptide line, and have developed and own two growing products within the PBP market, all of which will benefit from further market penetration and expansion.
Their strategy is to grow organically by focusing on new product development and expanding the application of PBP products. This strategic component involves further penetrating existing markets, capitalizing on the favorable macrodemographic trends, and expanding the established distribution network.
How does this boil down to dead Presidents and Franklins? You want the truth? You can’t handle the truth! In November, AOB reported their 3rd quarter results for 2006:
Third Quarter 2006 Highlights:
-- Organic Revenue Growth of 63% during the Quarter
-- Consolidated Gross Margins improve 3.5% versus last year to 66.9%
-- Management Expects Fourth Quarter Revenue to be in the range of $37 million to $39 million and at least $0.15 in EPS
For the third quarter 2006, the Company reported revenues of $27.1 million, an increase of 101.9 percent compared to $13.4 million in the third quarter of last year. The increase in total revenues for the quarter from last year was driven by strong organic growth in the Company's Plant-based Pharmaceutical (PBP) and Plant-based Nutraceutical (PBN) line of products and as a result of continuing momentum from the acquisition of Guangxi Lingfeng Pharmaceutical Co. Ltd. (GLP) earlier this year. During the third quarter, PBP sales, including GLP products, increased by 130.5 percent to $19.9 million compared to the third quarter last year. Sales of the Company's Cease Enuresis Soft Gel and Patch increased 117.8 percent to $6.6 million as compared to last year with sales of the Company's Shuanghuanlian Injection Powder increasing 51.5 percent to $6.5 million.
We all know it makes money, but will this move the stock price? Remember the mantra…earnings earnings earnings. ANAL-ysts say that AOB will earn $0.10/share next quarter, $0.43/share for this year and $0.58/share for next year. Excuse me while I siss in my pants laughing. AOB is growing its revenues sequentially EACH QUARTER. This growth is ACCELERATING. This is revenue growth, not just earnings growth. Their making it because their selling more stuff which means that their fixed costs become smaller and smaller per unit sales so their overall margin gets larger and larger. The growth rate is ridiculous. Why?
Simple…I’m smarter than the ANAL-ysts and can determine this with my Wharton MBA training. In July 2006, the company acquired HQPL, a distributor of pharmaceutical products throughout China, for approximately $4 million. This acquisition will substantially broaden the number of distribution points for its product portfolio form 10,000 to 100,000, and will enable AOB to sell throughout all regions of China. This was BRILLIANT strategy.
They can and will sustain this growth for at least another 3 quarters, which $$$MR. MARKET$$$ says will earn them $0.46/share in 2006 on revenues of $108 million. When their products hit the street from these new outlets, 2007 revenues will balloon to $206 million with EPS of $1.03. If you take the forward PE that the ANAL-ysts gave us (22) and multiply it by $1.03, you get a share price of $22.66 which is well past my target price.
The boss is so excited I think he hasta go siss.
"I am pleased to report that our business continues to experience strong momentum as we reported the highest quarterly revenue and net income in the Company's history as we continue to penetrate the Chinese market and reinvigorate consumer brand awareness for GLP products in the women's health market," commented Tony Liu, Chairman and CEO of AOB. "We are pleased with the performance of our most recent initiatives, which include increased advertising and the expansion of our distribution channels through the acquisition of HQPL, as AOB becomes a recognized brand across China. We believe our orders for GLP products scheduled for delivery in the fourth quarter will exceed our projection of $6 million announced at the end of September."
Mr. Liu concluded, "Based on improving visibility and confidence in our business we are going to begin providing quarterly revenue and earnings per share guidance beginning with our fourth quarter 2006 results. At this time we expect the fourth quarter revenue to be in the range of $37 million to $39 million with diluted earnings per share of at least $0.15, which would represent approximately 88 percent to 98 percent revenue growth from the comparable quarter last year with EPS increasing approximately 67 percent versus last year."
This guy ain’t no dummy. Liu holds an EMBA degree and is an experienced entrepreneur. He was in the military for over 19 years and held a high rank commander position when he was with the People’s Liberation Army. After Mr. Liu left the army, he started working for the government of Heilongjiang province. Mr. Liu accumulated and possesses many years of working experience while he witnessed and participated in the massive macro economic changes in China. Mr. Liu was one of the representatives to the National People’s Congress. During the last thirteen years, Mr. Liu has led and managed the Company as its Chief Executive Officer. He has more than ten years of experience in managing pharmaceutical companies. Mr. Liu was named the Outstanding Chinese Entrepreneur of the World and he is currently the Vice Chairman of the International Chinese Entrepreneur Association.
I guess if he eats his products, he won’t have to go to the “loo” in the middle of the night. Ha ha ha. I murder me!
Let me know what you think of this write up. I always like to hear from you, and frankly I don't even know if you read down this far or if you even get my email, so drop me a line.
If you liked the write up, send it on to three friends.
If you really liked it, go to this website: http://www.golittletigers.com .
These kids are working hard to make their football team something special, and they need your help (I'm the acting President of its Booster Club).
I am HUGE!!
$$$MR. MARKET$$$
All of a sudden you start having these weird dreams. You’re driving in a car and need to pull over to the side of the road to go siss. Or, you’re at a football game and you get up to go to the men’s room and you can’t find it. Or you’re back in high school, and you ask the teacher for a hall pass, and he doesn’t give it to you. Finally, you wake up with the revelation that you have to go siss like a Russian race horse. So you go to your bathroom, open up your fire hose, take care of bitness and go try to go back to sleep. The only problem is that now your head is throbbing like 10 pounds of poop in a 3 pound bag.
Or how about this scenario? You schedule a morning meeting at 10 am. This way you get to sleep an extra hour. But at 6 am, you get that urge to go siss. You get up and take care of bitness, but now you can’t go back to sleep.
Or how about this story? Titan Omega went up on the roof to siss. He gets too close to the edge and takes the fast elevator down.
Or how about this story? A Yale graduate and a Wharton MBA wakes up in the middle of the night, sleepwalks to his refrigerator and waters his lettuce.
All of these stories are true and truth IS stranger than fiction.
Wouldn’t it be great if there were some ancient Chinese herb you could take to make you suppress the urge to go siss when you don’t really have to? Now you don’t have to dream.
Today I bought AOB, American Oriental Bioengineering, at 12.25. I will sell it in 4 - 6 weeks 14.15. Here’s why I like AOB:
AOB’s stock is up 184% in the last 12 months, yet it’s still very cheap. Even though its present P/E is 33, it’s accelerating growth and earnings puts its forward P/E ratio at only 22. Look at this chart…it’s ramping up:
American Oriental Bioengineering, Inc. engages in the development and production of plant-based pharmaceutical (PBP) products and plant-based nutraceutical (PBN) products in China. Its PBP products include cease enuresis soft gel, which is used to alleviate bed-wetting and urination disorder; double ginseng yishen grain that is used for neurosis, vegetative nerve functional disturbance, and hypo-immunity; root of red-rooted salvia tablet that improves blood circulation and blood flow to the coronary artery to relieve pain, and is used for coronary ischemia and angina pectoris caused by coronary heart disease; and urinstopper patch, which is used to avoid frequent urination, urinal incontinence, and bed wetting.
Their two big products are SoyPeptide Beverage. The product contains Soybean Peptide which is extracted from the Soy Protein Isolate through enzyme reaction, is composed of 3 to 6 amino acid with molecular weight less than 1,000d. Peptide is absorbed and digested by our body more directly than amino acid, is low in sensitivity and zero in cholesterol that is good to health. It also consists of complete plant protein, rich in 9 kinds of essential amino acids that make rapid recovery of energy, as well as accelerating the power of brain. Further, it is also good for energy metabolism. This product is added with soybean peptide and condensed ribes nigrum, which is rich in vitamins and minerals, is very good to our health.
The other one is Cease-enuresis soft gel
Chinese spelling：Yiniaoting Jiaonang
Ingredients】Hulled seed cream of shinyleaf yellowhorn.
Character】 This products are in brown granules, slightly sweet and acerbity in flavor
Pharmacological action】 This product can reduce micturition times of water loading in mice; increase sphincter vesicae discharge frequency of a rat, enlarging scope,as well as prolong discharge period, as a result shrink sphincter vesicae. The in vitro studies indicated this product also can resist the shrinkage of white rat's bladder smooth muscle caused by acetylcholine, as well as reduce its tension. What? No more shrinkage? Now I can go in the pool?
We all agree that medicine is getting expensive. People, wisely, will turn to non-prescription herbal products if they work. How do you know if they work? Word of mouth is the tried and true way. This stuff actually seems to be working. How do I know this? Do people buy Ipods? People are buying AOB’s products. It seems to work, and people like telling their friends about it, especially if it works.
AOB has, in the last ten years, grown from a start-up in 1994 with about $100,000 of revenue to become a leading manufacturer of plant-based pharmaceutical products and plant-based nutraceutical products for the rapidly growing Chinese market. They operate in a large and growing market. The total pharmaceutical and nutraceutical market in China was approximately $62 billion in 2004. Demographic trends in this market are favorable, as the Chinese population continues to grow and age and economic expansion in China creates wealth, which serves to increase the number of citizens who can afford healthcare. With the total market for pharmaceutical products in China, herbal and plant-based pharmaceutical remedies and products have an extensive history. Many Chinese consumers and doctors rely upon the use of plant-based products for treatment of a variety of different ailments, consistent with the Eastern philosophy of health and wellness. AOB's standing could open the way to a raft of new biotech developed foods in China, particularly as the country races to meet rising demand for processed foods in an effort to feed its still burgeoning population – currently said to stand at 1.3 billion people. The supply of soy products has proved particularly problematic in recent years, leading the country to become a net importer of soybeans.
The company's research team reports that the growth of liver cancer cells inside mice was ‘successfully suppressed' by soybean protein peptides without side effects. Their findings could lead to future market opportunities for the ingredient. Soy is the most widely used botanical by pre- and post-menopausal women but its use by men is also growing as research continues to show the benefits on heart health. In the US, soy sales have grown from $940 million in 1990 to a projected $4 billion this year.
AOB currently has more than 100 products in their portfolio, all plant-based in formulation divided into two key categories: plant-based pharmaceuticals and plant-based nutraceuticals. PBP is the larger of the Company’s two divisions as a percentage of revenue. PBP products in China require approval from the state FDA and are administered both through over-the-counter locations and through prescriptions at hospitals and clinics. The two largest products in the PBP category are Shuanghuanglian Powder Injection and Cease Enuresis Soft Gel. SLPI, our largest contributing product, as a percent of total revenue is one of the only two PBP herbal injections approved by the China state FDA for treating anti-viral indications. Cease Enuresis Soft Gel is approved by the China state FDA as a prescription remedy for chronic bedwetting and nighttime urination. Bedwetting is a serious problem affecting millions of children and adults. Leveraging on our Cease-Enuresis Soft Gel and the newly established research center, we believe the Company can capture a substantial market share of serving patients suffering from enuresis or chronic bedwetting syndrome
PBN is the smaller of the Company’s two divisions. PBN products are not licensed by the China state FDA, but they generally require local government approval and are typically sold over the counter at the retail outlets. AOBO’s PBN division products soybean peptide products in powder and liquid forms. Soybean peptide is a cholesterol-free energy-boosting protein source that enhances the immune system and has anti-fatigue benefits. AOBO also produces a line of nutritional products through the PBN division, including the Three-Happiness nutritional drink, which are rich in vitamins and amino acids to enhance well-being and to provide energy The Three-Happiness product line is a recognized retail brand name in China.
AOB owns a very recognizable brand in China with their Three-Happiness nutritional beverages and the soy protein peptide line, and have developed and own two growing products within the PBP market, all of which will benefit from further market penetration and expansion.
Their strategy is to grow organically by focusing on new product development and expanding the application of PBP products. This strategic component involves further penetrating existing markets, capitalizing on the favorable macrodemographic trends, and expanding the established distribution network.
How does this boil down to dead Presidents and Franklins? You want the truth? You can’t handle the truth! In November, AOB reported their 3rd quarter results for 2006:
Third Quarter 2006 Highlights:
-- Organic Revenue Growth of 63% during the Quarter
-- Consolidated Gross Margins improve 3.5% versus last year to 66.9%
-- Management Expects Fourth Quarter Revenue to be in the range of $37 million to $39 million and at least $0.15 in EPS
For the third quarter 2006, the Company reported revenues of $27.1 million, an increase of 101.9 percent compared to $13.4 million in the third quarter of last year. The increase in total revenues for the quarter from last year was driven by strong organic growth in the Company's Plant-based Pharmaceutical (PBP) and Plant-based Nutraceutical (PBN) line of products and as a result of continuing momentum from the acquisition of Guangxi Lingfeng Pharmaceutical Co. Ltd. (GLP) earlier this year. During the third quarter, PBP sales, including GLP products, increased by 130.5 percent to $19.9 million compared to the third quarter last year. Sales of the Company's Cease Enuresis Soft Gel and Patch increased 117.8 percent to $6.6 million as compared to last year with sales of the Company's Shuanghuanlian Injection Powder increasing 51.5 percent to $6.5 million.
We all know it makes money, but will this move the stock price? Remember the mantra…earnings earnings earnings. ANAL-ysts say that AOB will earn $0.10/share next quarter, $0.43/share for this year and $0.58/share for next year. Excuse me while I siss in my pants laughing. AOB is growing its revenues sequentially EACH QUARTER. This growth is ACCELERATING. This is revenue growth, not just earnings growth. Their making it because their selling more stuff which means that their fixed costs become smaller and smaller per unit sales so their overall margin gets larger and larger. The growth rate is ridiculous. Why?
Simple…I’m smarter than the ANAL-ysts and can determine this with my Wharton MBA training. In July 2006, the company acquired HQPL, a distributor of pharmaceutical products throughout China, for approximately $4 million. This acquisition will substantially broaden the number of distribution points for its product portfolio form 10,000 to 100,000, and will enable AOB to sell throughout all regions of China. This was BRILLIANT strategy.
They can and will sustain this growth for at least another 3 quarters, which $$$MR. MARKET$$$ says will earn them $0.46/share in 2006 on revenues of $108 million. When their products hit the street from these new outlets, 2007 revenues will balloon to $206 million with EPS of $1.03. If you take the forward PE that the ANAL-ysts gave us (22) and multiply it by $1.03, you get a share price of $22.66 which is well past my target price.
The boss is so excited I think he hasta go siss.
"I am pleased to report that our business continues to experience strong momentum as we reported the highest quarterly revenue and net income in the Company's history as we continue to penetrate the Chinese market and reinvigorate consumer brand awareness for GLP products in the women's health market," commented Tony Liu, Chairman and CEO of AOB. "We are pleased with the performance of our most recent initiatives, which include increased advertising and the expansion of our distribution channels through the acquisition of HQPL, as AOB becomes a recognized brand across China. We believe our orders for GLP products scheduled for delivery in the fourth quarter will exceed our projection of $6 million announced at the end of September."
Mr. Liu concluded, "Based on improving visibility and confidence in our business we are going to begin providing quarterly revenue and earnings per share guidance beginning with our fourth quarter 2006 results. At this time we expect the fourth quarter revenue to be in the range of $37 million to $39 million with diluted earnings per share of at least $0.15, which would represent approximately 88 percent to 98 percent revenue growth from the comparable quarter last year with EPS increasing approximately 67 percent versus last year."
This guy ain’t no dummy. Liu holds an EMBA degree and is an experienced entrepreneur. He was in the military for over 19 years and held a high rank commander position when he was with the People’s Liberation Army. After Mr. Liu left the army, he started working for the government of Heilongjiang province. Mr. Liu accumulated and possesses many years of working experience while he witnessed and participated in the massive macro economic changes in China. Mr. Liu was one of the representatives to the National People’s Congress. During the last thirteen years, Mr. Liu has led and managed the Company as its Chief Executive Officer. He has more than ten years of experience in managing pharmaceutical companies. Mr. Liu was named the Outstanding Chinese Entrepreneur of the World and he is currently the Vice Chairman of the International Chinese Entrepreneur Association.
I guess if he eats his products, he won’t have to go to the “loo” in the middle of the night. Ha ha ha. I murder me!
Let me know what you think of this write up. I always like to hear from you, and frankly I don't even know if you read down this far or if you even get my email, so drop me a line.
If you liked the write up, send it on to three friends.
If you really liked it, go to this website: http://www.golittletigers.com .
These kids are working hard to make their football team something special, and they need your help (I'm the acting President of its Booster Club).
I am HUGE!!
$$$MR. MARKET$$$
What the heck does little peanuts know, anyway?
Comment